United States v. Vega-Figueroa

139 F.4th 77
CourtCourt of Appeals for the First Circuit
DecidedJune 4, 2025
Docket23-1125
StatusPublished
Cited by1 cases

This text of 139 F.4th 77 (United States v. Vega-Figueroa) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Vega-Figueroa, 139 F.4th 77 (1st Cir. 2025).

Opinion

United States Court of Appeals For the First Circuit

No. 23-1125

UNITED STATES OF AMERICA,

Appellee,

v.

JOSÉ A. VEGA-FIGUEROA, a/k/a Pito Casco,

Defendant, Appellant.

APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF PUERTO RICO

[Hon. Daniel R. Domínguez, U.S. District Judge]

Before

Barron, Chief Judge, Gelpí and Montecalvo, Circuit Judges.

Frank D. Inserni Milam for appellant.

Jeniffer Vélez Pérez, Assistant United States Attorney, with whom W. Stephen Muldrow, United States Attorney, and Mariana E. Bauzá-Almonte, Assistant United States Attorney, Chief, Appellate Division, were on brief, for appellee.

June 4, 2025 GELPÍ, Circuit Judge. Defendant-Appellant José A.

Vega-Figueroa ("Vega") is serving multiple life sentences for his

role in a 1990s drug-trafficking operation. In February 2021,

Vega sought release from prison by moving for compassionate

release. The district court denied that motion and Vega now

appeals, contending that the district court neither adequately

addressed his "extraordinary and compelling" reasons for release

nor adequately addressed the 18 U.S.C. § 3553(a) sentencing

factors. For the reasons that follow, we affirm.

I. Background

Vega has appeared before this court many times. See,

e.g., United States v. Vega-Figueroa, 234 F.3d 744, 747 (1st Cir.

2000); United States v. Vega-Figueroa, No. 09-1077 (1st Cir.

July 29, 2009); United States v. Vega-Figueroa, No. 12-1754 (1st

Cir. Aug. 8, 2012); United States v. Vega-Figueroa, No. 14-1247

(1st Cir. Mar. 31, 2015); United States v. Vega-Figueroa, No.

18-1906 (1st Cir. Aug. 26, 2019). Consequently, we assume the

parties' familiarity with much of the procedural and factual

- 2 - background and recite here only the information necessary to

explain our decision.1

In 1994, Vega was charged in the Superior Court of Puerto

Rico, Carolina Section, with ten counts related to various criminal

offenses. See Vega-Figueroa, slip op. at 1. Those charges

included, in relevant part: (1) unlawful possession, use, and

transportation of several guns; and (2) two counts of first-degree

murder for the deaths of Reynaldo Colón González ("Colón González")

and Melvin Flores-Montalvo ("Flores-Montalvo"). Id. On

October 11, 1995, a jury acquitted Vega of all charges. Id.

In 1997, however, a federal grand jury returned an

indictment against Vega. Id. at 2. It was alleged that Vega,

along with a co-defendant, was "in charge of an extensive criminal

enterprise involving the sale and distribution of heroin, cocaine,

crack cocaine, and marijuana" in Puerto Rico between 1990 and 1997.

Vega-Figueroa, 234 F.3d at 748. As the district court in that

case described it, the enterprise was a "very dangerous and violent

drug gang." See Vega-Figueroa, slip op. at 4. The indictment

charged Vega with various counts, including: (1) aiding and

abetting in a continuing criminal enterprise; (2) conspiring to

distribute in excess of five kilograms of heroin, in excess of

1The district court's Opinion and Order provides a more fulsome history. See United States v. Vega-Figueroa, No. 3:97-cr-00072-CVR, slip op. at 1-4 (D.P.R. Dec. 12, 2022).

- 3 - five kilograms of cocaine, and in excess of 100 kilograms of

marijuana; and (3) the unlawful use of firearms during and in

relation to a drug-trafficking offense. The indictment also listed

the aforementioned murders of Colón González and Flores-Montalvo

as overt acts in furtherance of the conspiracy. After a thirty-day

trial, the federal jury found Vega guilty on all counts.

Following the verdict, a Presentence Investigation

Report ("PSR") was prepared; it set forth a base offense level of

43. The PSR included homicide-related facts, which were the basis

for an increase in Vega's sentencing exposure under the

then-mandatory United States Sentencing Guidelines. The district

court sentenced Vega on February 19, 1999. The district court's

sentence included concurrent life sentences, one each as to Counts

One and Two, and a five-year term as to Count Three.

Shortly after sentencing, Vega appealed his conviction

and sentence to this court. See Vega-Figueroa, 234 F.3d 744. In

that appeal, Vega raised ten issues, including various evidentiary

challenges. Id. at 747-57. We affirmed Vega's conviction after

evaluating his contentions. Id. at 758. Following our decision,

Vega unsuccessfully continued to seek relief from his sentence.

See, e.g., Mot. for Retroactive Appl. of Sentencing Guidelines,

No. 3:97-cr-00072-CVR (D.P.R. May 14, 2008), ECF No. 758; Mot. to

Vacate Sentence, No. 3:97-cr-00072-CVR (D.P.R. Nov. 12, 2013), ECF

- 4 - No. 917; Mot. to Validate, No. 3:97-cr-00072-CVR (D.P.R. June 28,

2016), ECF No. 1014.

The procedural history of the present appeal is

comparatively short. Vega filed a request for compassionate

release with the Bureau of Prisons ("BOP") on May 11, 2020. There,

he emphasized his increased risk of complications from COVID-19,

given his preexisting medical conditions. On July 20, 2020, the

Warden of FCI Coleman -- FCI Coleman being the location where Vega

is incarcerated -- denied Vega's request, citing the BOP's

"extraordinary measures to contain the spread of COVID-19."2 Vega

then moved for compassionate release in the District of Puerto

Rico on February 8, 2021.

Vega's motion was brought pursuant to 18 U.S.C.

§ 3582(c)(1)(a), the provision governing sentence reductions

(colloquially known as the compassionate release provision). Vega

argued that he was entitled to relief due, in part, to the BOP's

allegedly negligent monitoring and treatment of his type 2 diabetes

and his increased risk of COVID-19-related complications due to

his diabetes. He also emphasized his "having been placed in

jeopardy twice for the same conduct on like charges (murder in the

2 Vega refers to the prison where he is housed as "FCC Coleman," while the government refers to it as "FCI Coleman." Federal Correctional Institution, Coleman, "FCI Coleman," is an Institution located within the Federal Correctional Complex, Coleman, "FCC Coleman." We adopt "FCI Coleman" here.

- 5 - first degree)." Finally, Vega asserted that his rehabilitation

efforts, analyzed under the 18 U.S.C. § 3553(a) sentencing

factors, supported a sentence reduction.

The government opposed Vega's motion, arguing that Vega

had presented neither extraordinary and compelling reasons for

compassionate release nor evidence that he was not a danger to the

community. The government pressed that Vega's health conditions

did not rise to the level of severity required under the U.S.S.G.

§ 1B1.13 policy statement.3 Further, in arguing that Vega

continued to present a danger to the community, the government

highlighted Vega's central role in the "dangerous and violent"

drug gang.4

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
139 F.4th 77, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-vega-figueroa-ca1-2025.